Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases

M. de Boer; E. M. M. Adang; K. C. G. Van Dycke; J. A. A. M. van Dijck; G. F. Borm; S. C. Seferina; C. H. M. van Deurzen; P. J. van Diest; P. Bult; A. R. T. Donders; V. C. G. Tjan-Heijnen

doi:10.1093/annonc/mds051

Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases

M. de Boer, E. M. M. Adang, K. C. G. Van Dycke, J. A. A. M. van Dijck, G. F. Borm, S. C. Seferina, C. H. M. van Deurzen, P. J. van Diest, P. Bult, A. R. T. Donders, V. C. G. Tjan-Heijnen^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	2585-2591
Journal	Annals of Oncology
Volume	23
Issue number	10
DOIs	https://doi.org/10.1093/annonc/mds051
Publication status	Published - Oct 2012

Keywords

adjuvant systemic therapy
breast cancer
cost-effectiveness
isolated tumor cells
micrometastases

Access to Document

10.1093/annonc/mds051

Cite this

de Boer, M., Adang, E. M. M., Van Dycke, K. C. G., van Dijck, J. A. A. M., Borm, G. F., Seferina, S. C., van Deurzen, C. H. M., van Diest, P. J., Bult, P., Donders, A. R. T., & Tjan-Heijnen, V. C. G. (2012). Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases. Annals of Oncology, 23(10), 2585-2591. https://doi.org/10.1093/annonc/mds051

de Boer, M. ; Adang, E. M. M. ; Van Dycke, K. C. G. ; van Dijck, J. A. A. M. ; Borm, G. F. ; Seferina, S. C. ; van Deurzen, C. H. M. ; van Diest, P. J. ; Bult, P. ; Donders, A. R. T. ; Tjan-Heijnen, V. C. G. / Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases. In: Annals of Oncology. 2012 ; Vol. 23, No. 10. pp. 2585-2591.

@article{73797241919242268d5ed5f7b2eb2a5e,

title = "Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases",

keywords = "adjuvant systemic therapy, breast cancer, cost-effectiveness, isolated tumor cells, micrometastases",

author = "{de Boer}, M. and Adang, {E. M. M.} and {Van Dycke}, {K. C. G.} and {van Dijck}, {J. A. A. M.} and Borm, {G. F.} and Seferina, {S. C.} and {van Deurzen}, {C. H. M.} and {van Diest}, {P. J.} and P. Bult and Donders, {A. R. T.} and Tjan-Heijnen, {V. C. G.}",

year = "2012",

month = oct,

doi = "10.1093/annonc/mds051",

language = "English",

volume = "23",

pages = "2585--2591",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "10",

}

de Boer, M, Adang, EMM, Van Dycke, KCG, van Dijck, JAAM, Borm, GF, Seferina, SC, van Deurzen, CHM, van Diest, PJ, Bult, P, Donders, ART & Tjan-Heijnen, VCG 2012, 'Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases', Annals of Oncology, vol. 23, no. 10, pp. 2585-2591. https://doi.org/10.1093/annonc/mds051

Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases. / de Boer, M.; Adang, E. M. M.; Van Dycke, K. C. G.; van Dijck, J. A. A. M.; Borm, G. F.; Seferina, S. C.; van Deurzen, C. H. M.; van Diest, P. J.; Bult, P.; Donders, A. R. T.; Tjan-Heijnen, V. C. G.

In: Annals of Oncology, Vol. 23, No. 10, 10.2012, p. 2585-2591.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Cost-effectiveness of adjuvant systemic therapy in low-risk breast cancer patients with nodal isolated tumor cells or micrometastases

AU - de Boer, M.

AU - Adang, E. M. M.

AU - Van Dycke, K. C. G.

AU - van Dijck, J. A. A. M.

AU - Borm, G. F.

AU - Seferina, S. C.

AU - van Deurzen, C. H. M.

AU - van Diest, P. J.

AU - Bult, P.

AU - Donders, A. R. T.

AU - Tjan-Heijnen, V. C. G.

PY - 2012/10

Y1 - 2012/10

KW - adjuvant systemic therapy

KW - breast cancer

KW - cost-effectiveness

KW - isolated tumor cells

KW - micrometastases

U2 - 10.1093/annonc/mds051

DO - 10.1093/annonc/mds051

M3 - Article

C2 - 22449731

VL - 23

SP - 2585

EP - 2591

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 10

ER -